Advisory Committee which has been convened to oversee a three-year study on the use of furosemide (also known as “Lasix”) on horses during the 48-hour period before the start of a Covered Horserace
HISA Announces Members of Furosemide Advisory Committee bloodhorse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloodhorse.com Daily Mail and Mail on Sunday newspapers.
ADVERTISEMENT
The use of bisphosphonates to manage bone disorders such as navicular syndrome, especially in race and performance horses, has become a recent (and controversial) topic of discussion in the equine veterinary community. Until now, no studies have been published describing the drug’s disposition in horse bones an important consideration when assessing its side effects.
A team from the University of California, Davis, (UC Davis) and the University of Kentucky recently took the first step toward describing bisphosphonates’ residence time in horses’ bones. Heather K. Knych, DVM, PhD, Dipl. ACVCP, professor of Clinical Veterinary Pharmacology at UC Davis’ K.L. Maddy Equine Analytical Pharmacology Lab, presented their findings at the 2020 American Association of Equine Practitioners’ convention, held virtually.